Germline BRCA1/2 mutations and severe haematological toxicities in patients with breast cancer treated with neoadjuvant chemotherapy
Year: 2021
Type: article
Source: European Journal of Cancer
Authors: Jenny Furlanetto, Volker Möbus, Andreas Schneeweiss, Kerstin Rhiem, Hans Tesch, Jens-Uwe Blohmer, Kristina Lübbe, Michael Untch, Christoph Salat, Jens Huober, Peter Klare, Rita Schmutzler, Fergus J. Couch, Bianca Lederer, Bernd Gerber, Dirk-Michael Zahm, Ingo Bauerfeind, Valentina Nekljudova, Claus Hanusch, Christian Jackisch, Theresa Link, Eric Hahnen, Sibylle Loibl, Peter A. Fasching
Institutions: German Breast Group, University Hospital Frankfurt, German Cancer Research Center, National Center for Tumor Diseases, University Hospital Cologne, Charité – Universitätsmedizin Berlin, Diakovere, Helios Hospital Berlin-Buch, University Hospital Ulm, Mayo Clinic, Klinikum Südstadt Rostock, SRH Wald-Klinikum Gera, Sana Klinikum Offenbach, University Hospital Carl Gustav Carus, Technische Universität Dresden, Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitätsklinikum Erlangen, Comprehensive Cancer Center Erlangen
Language: English
Subfield: Genetics
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W3121034072